The global Blood Screening and Typing market size was valued at USD 6861.3 million in 2023 and is forecast to a readjusted size of USD 8256.5 million by 2030 with a CAGR of 2.7% during review period.
Blood Screening definition: because can transmit a variety of serious infectious diseases such as hepatitis b, hepatitis c, AIDS and syphilis through blood.In order to ensure the safety of blood for clinical use, the quality of blood products, and to prevent cross-infection between blood supplies and the health of workers who collect blood and blood products, it is necessary to prevent the patients infected with the above diseases from entering the blood supply team, and prevent the direct transfusion of plasma positive for the pathogens of the above diseases to patients or for the production of blood products.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report includes an overview of the development of the Blood Screening and Typing industry chain, the market status of Reference Laboratories (Nucleic Acid Amplification Technology, Immunohematology), Standalone Blood Banks (Nucleic Acid Amplification Technology, Immunohematology), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Blood Screening and Typing.
Regionally, the report analyzes the Blood Screening and Typing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Blood Screening and Typing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Blood Screening and Typing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Blood Screening and Typing industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Nucleic Acid Amplification Technology, Immunohematology).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Blood Screening and Typing market.
Regional Analysis: The report involves examining the Blood Screening and Typing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Blood Screening and Typing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Blood Screening and Typing:
Company Analysis: Report covers individual Blood Screening and Typing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Blood Screening and Typing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Reference Laboratories, Standalone Blood Banks).
Technology Analysis: Report covers specific technologies relevant to Blood Screening and Typing. It assesses the current state, advancements, and potential future developments in Blood Screening and Typing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Blood Screening and Typing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Blood Screening and Typing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Nucleic Acid Amplification Technology
Immunohematology
Microbiological Technique
Other
麻豆原创 segment by Application
Reference Laboratories
Standalone Blood Banks
Hospitals
麻豆原创 segment by players, this report covers
Abbott Laboratories
Agena Bioscience
Axo Science
Bag Health Care Gmbh
Becton, Dickinson
Bio-Rad Laboratories
Biomerieux
Danaher
Day Medical
Diagast
F. Hoffmann-La Roche
Grifols
Immucor
Novacyt Group
Ortho Clinical Diagnostics
Quotient
Siemens Healthcare
Thermo Fisher Scientific
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Blood Screening and Typing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Blood Screening and Typing, with revenue, gross margin and global market share of Blood Screening and Typing from 2019 to 2024.
Chapter 3, the Blood Screening and Typing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Blood Screening and Typing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Screening and Typing.
Chapter 13, to describe Blood Screening and Typing research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Blood Screening and Typing
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Blood Screening and Typing by Type
1.3.1 Overview: Global Blood Screening and Typing 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Blood Screening and Typing Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Nucleic Acid Amplification Technology
1.3.4 Immunohematology
1.3.5 Microbiological Technique
1.3.6 Other
1.4 Global Blood Screening and Typing 麻豆原创 by Application
1.4.1 Overview: Global Blood Screening and Typing 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Reference Laboratories
1.4.3 Standalone Blood Banks
1.4.4 Hospitals
1.5 Global Blood Screening and Typing 麻豆原创 Size & Forecast
1.6 Global Blood Screening and Typing 麻豆原创 Size and Forecast by Region
1.6.1 Global Blood Screening and Typing 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Blood Screening and Typing 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Blood Screening and Typing 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Blood Screening and Typing 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Blood Screening and Typing 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Blood Screening and Typing 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Blood Screening and Typing 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Blood Screening and Typing Product and Solutions
2.1.4 Abbott Laboratories Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Agena Bioscience
2.2.1 Agena Bioscience Details
2.2.2 Agena Bioscience Major Business
2.2.3 Agena Bioscience Blood Screening and Typing Product and Solutions
2.2.4 Agena Bioscience Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Agena Bioscience Recent Developments and Future Plans
2.3 Axo Science
2.3.1 Axo Science Details
2.3.2 Axo Science Major Business
2.3.3 Axo Science Blood Screening and Typing Product and Solutions
2.3.4 Axo Science Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Axo Science Recent Developments and Future Plans
2.4 Bag Health Care Gmbh
2.4.1 Bag Health Care Gmbh Details
2.4.2 Bag Health Care Gmbh Major Business
2.4.3 Bag Health Care Gmbh Blood Screening and Typing Product and Solutions
2.4.4 Bag Health Care Gmbh Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Bag Health Care Gmbh Recent Developments and Future Plans
2.5 Becton, Dickinson
2.5.1 Becton, Dickinson Details
2.5.2 Becton, Dickinson Major Business
2.5.3 Becton, Dickinson Blood Screening and Typing Product and Solutions
2.5.4 Becton, Dickinson Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Becton, Dickinson Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Blood Screening and Typing Product and Solutions
2.6.4 Bio-Rad Laboratories Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.7 Biomerieux
2.7.1 Biomerieux Details
2.7.2 Biomerieux Major Business
2.7.3 Biomerieux Blood Screening and Typing Product and Solutions
2.7.4 Biomerieux Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Biomerieux Recent Developments and Future Plans
2.8 Danaher
2.8.1 Danaher Details
2.8.2 Danaher Major Business
2.8.3 Danaher Blood Screening and Typing Product and Solutions
2.8.4 Danaher Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Danaher Recent Developments and Future Plans
2.9 Day Medical
2.9.1 Day Medical Details
2.9.2 Day Medical Major Business
2.9.3 Day Medical Blood Screening and Typing Product and Solutions
2.9.4 Day Medical Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Day Medical Recent Developments and Future Plans
2.10 Diagast
2.10.1 Diagast Details
2.10.2 Diagast Major Business
2.10.3 Diagast Blood Screening and Typing Product and Solutions
2.10.4 Diagast Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Diagast Recent Developments and Future Plans
2.11 F. Hoffmann-La Roche
2.11.1 F. Hoffmann-La Roche Details
2.11.2 F. Hoffmann-La Roche Major Business
2.11.3 F. Hoffmann-La Roche Blood Screening and Typing Product and Solutions
2.11.4 F. Hoffmann-La Roche Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.12 Grifols
2.12.1 Grifols Details
2.12.2 Grifols Major Business
2.12.3 Grifols Blood Screening and Typing Product and Solutions
2.12.4 Grifols Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Grifols Recent Developments and Future Plans
2.13 Immucor
2.13.1 Immucor Details
2.13.2 Immucor Major Business
2.13.3 Immucor Blood Screening and Typing Product and Solutions
2.13.4 Immucor Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Immucor Recent Developments and Future Plans
2.14 Novacyt Group
2.14.1 Novacyt Group Details
2.14.2 Novacyt Group Major Business
2.14.3 Novacyt Group Blood Screening and Typing Product and Solutions
2.14.4 Novacyt Group Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Novacyt Group Recent Developments and Future Plans
2.15 Ortho Clinical Diagnostics
2.15.1 Ortho Clinical Diagnostics Details
2.15.2 Ortho Clinical Diagnostics Major Business
2.15.3 Ortho Clinical Diagnostics Blood Screening and Typing Product and Solutions
2.15.4 Ortho Clinical Diagnostics Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
2.16 Quotient
2.16.1 Quotient Details
2.16.2 Quotient Major Business
2.16.3 Quotient Blood Screening and Typing Product and Solutions
2.16.4 Quotient Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 Quotient Recent Developments and Future Plans
2.17 Siemens Healthcare
2.17.1 Siemens Healthcare Details
2.17.2 Siemens Healthcare Major Business
2.17.3 Siemens Healthcare Blood Screening and Typing Product and Solutions
2.17.4 Siemens Healthcare Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 Siemens Healthcare Recent Developments and Future Plans
2.18 Thermo Fisher Scientific
2.18.1 Thermo Fisher Scientific Details
2.18.2 Thermo Fisher Scientific Major Business
2.18.3 Thermo Fisher Scientific Blood Screening and Typing Product and Solutions
2.18.4 Thermo Fisher Scientific Blood Screening and Typing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.18.5 Thermo Fisher Scientific Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Blood Screening and Typing Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Blood Screening and Typing by Company Revenue
3.2.2 Top 3 Blood Screening and Typing Players 麻豆原创 Share in 2023
3.2.3 Top 6 Blood Screening and Typing Players 麻豆原创 Share in 2023
3.3 Blood Screening and Typing 麻豆原创: Overall Company Footprint Analysis
3.3.1 Blood Screening and Typing 麻豆原创: Region Footprint
3.3.2 Blood Screening and Typing 麻豆原创: Company Product Type Footprint
3.3.3 Blood Screening and Typing 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Blood Screening and Typing Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Blood Screening and Typing 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Blood Screening and Typing Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Blood Screening and Typing 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Blood Screening and Typing Consumption Value by Type (2019-2030)
6.2 North America Blood Screening and Typing Consumption Value by Application (2019-2030)
6.3 North America Blood Screening and Typing 麻豆原创 Size by Country
6.3.1 North America Blood Screening and Typing Consumption Value by Country (2019-2030)
6.3.2 United States Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Blood Screening and Typing Consumption Value by Type (2019-2030)
7.2 Europe Blood Screening and Typing Consumption Value by Application (2019-2030)
7.3 Europe Blood Screening and Typing 麻豆原创 Size by Country
7.3.1 Europe Blood Screening and Typing Consumption Value by Country (2019-2030)
7.3.2 Germany Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Blood Screening and Typing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Blood Screening and Typing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Blood Screening and Typing 麻豆原创 Size by Region
8.3.1 Asia-Pacific Blood Screening and Typing Consumption Value by Region (2019-2030)
8.3.2 China Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Blood Screening and Typing Consumption Value by Type (2019-2030)
9.2 South America Blood Screening and Typing Consumption Value by Application (2019-2030)
9.3 South America Blood Screening and Typing 麻豆原创 Size by Country
9.3.1 South America Blood Screening and Typing Consumption Value by Country (2019-2030)
9.3.2 Brazil Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Blood Screening and Typing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Blood Screening and Typing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Blood Screening and Typing 麻豆原创 Size by Country
10.3.1 Middle East & Africa Blood Screening and Typing Consumption Value by Country (2019-2030)
10.3.2 Turkey Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Blood Screening and Typing 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Blood Screening and Typing 麻豆原创 Drivers
11.2 Blood Screening and Typing 麻豆原创 Restraints
11.3 Blood Screening and Typing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Blood Screening and Typing Industry Chain
12.2 Blood Screening and Typing Upstream Analysis
12.3 Blood Screening and Typing Midstream Analysis
12.4 Blood Screening and Typing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Abbott Laboratories
Agena Bioscience
Axo Science
Bag Health Care Gmbh
Becton, Dickinson
Bio-Rad Laboratories
Biomerieux
Danaher
Day Medical
Diagast
F. Hoffmann-La Roche
Grifols
Immucor
Novacyt Group
Ortho Clinical Diagnostics
Quotient
Siemens Healthcare
Thermo Fisher Scientific
听
听
*If Applicable.
